SCHEDULE 13D/A: Anixa Biosciences Insider Amit Kumar Increases Stake to 16.3%
Beneficial Ownership Update
Anixa Biosciences Inc. reports that insider Amit Kumar has increased his beneficial ownership in the company to 16.3% of outstanding common stock, up from 15.1%.
Summary
- Amit Kumar, a reporting person for Anixa Biosciences Inc., has increased his beneficial ownership in the company's common stock.
- As of June 4, 2025, Dr. Kumar beneficially owns 6,173,097 shares, representing 16.3% of the Issuer's outstanding common stock.
- This marks an increase from the 15.1% reported in his previous Amendment No. 7 to Schedule 13D.
- The change in ownership is attributed to market purchases, the vesting of previously outstanding stock options, and a change in the number of stock options exercisable within 60 days.
- The specific triggering event for this filing was Dr. Kumar's purchase of 10,000 shares of common stock on June 4, 2025.
- His holdings consist of 569,925 shares of common stock held directly and 5,603,172 shares of common stock issuable upon exercise of stock options exercisable within 60 days.
- Dr. Kumar retains sole voting and dispositive power over all beneficially owned shares.
Sentiment
Score: 7
Explanation: The increase in beneficial ownership by a key individual, partly through market purchases, suggests confidence in the company's prospects.
Positives
- Increased insider ownership by Amit Kumar, from 15.1% to 16.3%, potentially signaling confidence in the company's future.
- The increase is partly due to market purchases (10,000 shares), indicating direct investment by a key individual.
- Vesting of stock options contributes to the increased stake, reflecting long-term incentive alignment.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Increased insider ownership may be viewed positively, signaling management's confidence and alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 06/04/2025 | Date of event which requires filing of this statement (Dr. Kumar's purchase of 10,000 shares). |
| 06/06/2025 | Date of filing. |
Keywords
Anixa Biosciences Inc, Amit Kumar, Schedule 13D, beneficial ownership, insider ownership, common stock, stock options, SEC filing, ownership increase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.